Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001600
Filing Date
2025-03-31
Accepted
2025-03-31 14:06:25
Documents
69
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1824137
2 ex19-1.htm EX-19.1 107377
3 ex23-1.htm EX-23.1 4547
4 ex31-1.htm EX-31.1 12157
5 ex31-2.htm EX-31.2 11812
6 ex32-1.htm EX-32.1 10095
7 ex23-1_001.jpg GRAPHIC 21859
8 ex23-1_002.jpg GRAPHIC 138643
9 form10-k_001.jpg GRAPHIC 32352
10 form10-k_002.jpg GRAPHIC 16929
11 form10-k_003.jpg GRAPHIC 28005
12 form10-k_004.jpg GRAPHIC 23792
  Complete submission text file 0001641172-25-001600.txt   6758648

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE ptix-20241231.xsd EX-101.SCH 37476
14 XBRL CALCULATION FILE ptix-20241231_cal.xml EX-101.CAL 49617
15 XBRL DEFINITION FILE ptix-20241231_def.xml EX-101.DEF 198868
16 XBRL LABEL FILE ptix-20241231_lab.xml EX-101.LAB 396235
17 XBRL PRESENTATION FILE ptix-20241231_pre.xml EX-101.PRE 308887
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 678363
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12555 | Film No.: 25791549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)